CDH22 hypermethylation is an independent prognostic biomarker in breast cancer

BACKGROUND: Cadherin-like protein 22 (CDH22) is a transmembrane glycoprotein involved in cell-cell adhesion and metastasis. Its role in cancer is controversial because it has been described as being upregulated in colorectal cancer, whereas it is downregulated in metastatic melanoma. However, its st...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Epigenetics
Auteurs principaux: Martín-Sánchez, Esperanza, Mendaza, Saioa, Ulazia-Garmendia, Ane, Monreal-Santesteban, Iñaki, Córdoba, Alicia, Vicente-García, Francisco, Blanco-Luquin, Idoia, De La Cruz, Susana, Aramendia, Ana, Guerrero-Setas, David
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2017
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5270318/
https://ncbi.nlm.nih.gov/pubmed/28149335
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13148-016-0309-z
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires